| 2015 |
RNF152 is a lysosome-anchored E3 ubiquitin ligase that ubiquitinates RagA with K63-linked polyubiquitin chains in an amino-acid-sensitive manner, which recruits the GATOR1 GAP complex to inhibit RagA and thereby negatively regulates mTORC1 activation at the lysosome. RNF152 knockout causes hyperactivation of mTORC1 and protects cells from amino-acid-starvation-induced autophagy. |
Co-immunoprecipitation, in vivo ubiquitination assays, site-directed mutagenesis of RagA ubiquitination sites, RNF152 knockout cells, mTORC1 activity assays, autophagy assays |
Molecular cell |
High |
25936802
|
| 2010 |
RNF152 is a canonical RING finger E3 ubiquitin ligase localized to lysosomes (co-localizing with the lysosome marker LAMP3). It undergoes K48-linked polyubiquitination dependent on its RING finger and transmembrane domains, and its overexpression induces apoptosis in HeLa cells. |
In vivo ubiquitination assay, domain mutagenesis, co-localization with LAMP3 by fluorescence microscopy, overexpression apoptosis assay |
Protein & cell |
Medium |
21203937
|
| 2020 |
RNF152 positively regulates TLR/IL-1R signaling by directly interacting with the adaptor protein MyD88 and enhancing its oligomerization, which is required for downstream NF-κB activation. This function is independent of RNF152's E3 ubiquitin ligase activity. RNF152-deficient mice produce less inflammatory cytokines in response to LPS and are more resistant to LPS-induced lethal endotoxemia. |
Co-immunoprecipitation, overexpression/knockdown NF-κB reporter assays, RNF152-deficient mice, cytokine ELISA, MyD88 oligomerization assay |
EMBO reports |
High |
31930677
|
| 2024 |
Fasting-induced RNF152 ubiquitinates the Ragulator subunit p18, leading to its proteasomal degradation, reduction of lysosomal p18 localization, suppression of mTORC1 activity, inhibition of glycolysis, and resensitization of gallbladder cancer cells to gemcitabine. |
Ubiquitination assays, lentiviral overexpression/silencing, mTORC1 activity assays, glycolysis measurements, xenograft model |
iScience |
Medium |
38706841
|
| 2023 |
RNF152 directly binds IRAK1 and promotes its ubiquitination and proteasomal degradation, thereby reducing IRAK1-mediated AKR1B10 expression, suppressing fatty acid oxidation, and inhibiting metastasis of lung adenocarcinoma cells. |
Co-immunoprecipitation, ubiquitination assay, overexpression/knockdown functional assays, xenograft mouse model, fatty acid oxidation assays |
The American journal of pathology |
Medium |
37717980
|
| 2022 |
RNF152 negatively regulates Wnt/β-catenin signaling by inhibiting polymerization of Dishevelled in an E3 ligase-independent manner requiring its transmembrane domain. Overexpression inhibits β-catenin stabilization and Wnt target gene expression; knockdown enhances Wnt responses. RNF152 morphants in Xenopus show defects in neural crest formation. |
Overexpression and morpholino knockdown in Xenopus embryos, Wnt-responsive reporter assays, E3 ligase-dead and transmembrane-domain truncation mutants, Dishevelled polymerization assay |
BMB reports |
Medium |
35410636
|
| 2025 |
RNF152 ubiquitinates HSP27 at Lys114, targeting it for proteasomal degradation. RNF152-mediated HSP27 degradation activates the PI3K/AKT pathway, driving fibroblast-like synoviocyte proliferation and pro-inflammatory cytokine release in temporomandibular joint osteoarthritis. |
Immunoprecipitation-mass spectrometry, co-immunoprecipitation, co-localization imaging, protein docking, ubiquitination site mutagenesis, in vivo AAV-siRNF152 delivery in rat TMJOA model |
Arthritis research & therapy |
Medium |
41413572
|
| 2021 |
Overexpression of RNF152 in colon cancer cells (RKO) increases apoptosis and sensitizes cells to NO-donor-induced apoptosis, associated with decreased expression of anti-apoptotic proteins Bcl-2 and Bcl-XL. |
Flow cytometry apoptosis assay, western blot for Bcl-2/Bcl-XL, overexpression in RKO cells, NO donor treatment |
Zhonghua zhong liu za zhi [Chinese journal of oncology] |
Low |
34034471
|
| 2024 |
RNF152, as a short-lived lysosomal membrane protein, can be co-opted by heterobifunctional LYMTAC molecules to tether and deliver membrane-associated target proteins (including KRAS G12D) to the lysosome for degradation, demonstrating that RNF152 can mediate proximity-induced lysosomal targeting of non-native substrates. |
LYMTAC chimeric molecule treatment, KRAS relocalization imaging, phospho-ERK signaling assay, lysosomal degradation assay |
bioRxivpreprint |
Low |
bio_10.1101_2024.09.08.611923
|